Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Aldena Tx Emerges with $30m Investment from Medicxi (2023-03-16)
> Founded by Medicxi with Georgia Tech and UMass scientists, supported by US $30M investment from Medicxi > Developing advanced, long-lasting therapies for dermatological diseases through radical new transepidermal delivery of proprietary siRNAs > Led by derma...
Owlstone Medical Partners with Bicycle Therapeutics (2023-03-15)
> Research will focus on applying Bicycle’s bicyclic peptide technology to Owlstone’s EVOC probes > Antigen-targeted EVOC probes have potential for use in preclinical research, clinical trials, and as companion diagnostics and tests for early detection of disease...
CN Bio Appoints Deepak Singh as VP of Sales and Marketing (2023-03-14)
Key appointment as company seeks to continue global expansion of microphysiological systems and contract research service offerings CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems ...
Exscientia Regains Rights to Two Drug Candidates from BMS (2023-03-14)
— Precision designed LSD1 and MALT1 inhibitors currently progressing through IND-enabling studies — — Both m olecules demonstrate Exscientia’s ability to overcome critical design challenges and identify high quality drug candidates with potential increased proba...
Teitur Trophics Raises €28m Series A Financing (2023-03-14)
> Financing co-led by Sunstone Life Science Ventures and Sound Bioventures with participation from Industrifonden, Innovestor’s Life Science Fund and P53 Invest > Discovery of a novel mechanism with the potential to prevent the death of neurons in neurodegenerat...
Cancer Research UK & UCB to Develop Cancer Antibody Drugs (2023-03-09)
Cancer Research UK, the world’s largest charitable funder of cancer research, and UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical company, today announced a clinical development collaboration to advance two of UCB’s investigational oncology antibody candid...
Exscientia & Charité to Advance Precision Medicine Platform (2023-03-07)
— Partnership will further validate Exscientia’s functional drug testing platform to predict response in haematological cancers — Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Charité – Universitätsmedizin Berlin (Charité) to utilise E...
Oculis Lists at Nasdaq via SPAC Merger with $117m in Cash (2023-03-03)
> Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology company, under the ticker “OCS”, with advanced clinical-stage pipeline of multiple product candidates in key areas of medical needs such as retina, dry eye...
Antiverse: $3m Investment from New & Existing Investors (2023-03-01)
Seven human G-protein coupled receptor antibodies were characterised, showing high affinity and blocking function. $3 million USD investments will enable further development of these assets in-house. [picture] Structural model showing the 7 functional GPCR bin...
Five Alarm Bio Raises >£500k Seed Investment Round (2023-02-27)
> Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris > Funding will drive proprietary research into novel compounds that extend healthy lifespan of cells and tissues, with therapeutic ...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture EasyFairs Connect in Pharma 2023 Geneva Speakers 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)